XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Earnings Per Share

Below is the computation of basic and diluted earnings per share for the years ended December 31, 2023, 2022 and 2021:

(In thousands, except per share amounts)

 

2023

 

 

2022

 

 

2021

 

Computation of Basic Earnings per Share

 

 

 

 

 

 

 

 

 

Net income attributable to Stepan Company

 

$

40,204

 

 

$

147,153

 

 

$

137,804

 

Weighted-average number of shares outstanding

 

 

22,777

 

 

 

22,781

 

 

 

22,922

 

Basic earnings per share

 

$

1.77

 

 

$

6.46

 

 

$

6.01

 

Computation of Diluted Earnings per Share

 

 

 

 

 

 

 

 

 

Net income attributable to Stepan Company

 

$

40,204

 

 

$

147,153

 

 

$

137,804

 

Weighted-average number of shares outstanding

 

 

22,777

 

 

 

22,781

 

 

 

22,922

 

Add weighted-average net shares from assumed
   exercise of options (under treasury share method)
(1)

 

 

66

 

 

 

104

 

 

 

138

 

Add weighted-average net shares related to unvested
   stock awards (under treasury share method)

 

 

3

 

 

 

1

 

 

 

1

 

Add weighted-average net shares from assumed
   exercise of SARs (under treasury share method)

 

 

67

 

 

 

111

 

 

 

166

 

Add weighted-average contingently issuable net shares
   related to performance stock awards (under treasury
   share method)

 

 

33

 

 

 

67

 

 

 

60

 

Weighted-average shares applicable to diluted
   earnings

 

 

22,946

 

 

 

23,064

 

 

 

23,287

 

Diluted earnings per share

 

$

1.75

 

 

$

6.38

 

 

$

5.92

 

(1)
Options/SARs to purchase 672,485, 343,715 and 103,182 shares of the Company’s common stock were excluded from the computations of diluted earnings per share for the years ended December 31, 2023, 2022 and 2021, respectively. The options’/SARs’ exercise prices were greater than the average market price for the Company’s common stock and inclusion of the instruments would have had an antidilutive effect on the computations of earnings per share.